ArticleNagoya journal of medical science2021

S-1 facilitates canerpaturev (C-REV)-induced antitumor efficacy in a triple-negative breast cancer model.

Noriyuki Miyajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.